Burden of major Respiratory Diseases WHO Survey Ryazan region of Russia,

Slides:



Advertisements
Similar presentations
Predicting risks of asthma recurrence Stephen Watt Consultant in Respiratory and Hyperbaric Medicine Aberdeen Royal Infirmary.
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Michael W. Nash, MD Family Medicine Clinton County Rural Health Clinic Understanding COPD.
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Lesson 4 Care and Problems of the Respiratory System Respiratory system problems can affect the functioning of other body systems. Imagine not being able.
Professor of Respiratory Medicine
Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory.
Mobile clinics: How to improve access to health in remote areas? WHO Informal Technical Consultation BRAVE Geneva 6-7 November 2012 Dr Charles Senessie.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD Juliana Tambellini University of Pittsburgh.
COPD (Chronic Obstructive Pulmonary Disease)
 Chronic obstructive pulmonary disease (COPD) is one of the most common lung disease  Makes it difficult to breathe  There are two main forms of COPD.
1 Canadian Institute for Health Information. Disparities in Primary Health Care Experiences Among Canadians With Ambulatory Care Sensitive Conditions.
Patient Empowerment in Chronic Obstructive Pulmonary Disease (COPD) Noreen Baxter Respiratory Nurse Specialist May 2005.
Meredith G. Hennon, MPH and the Supercourse team in Pittsburgh.
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
Chronic Obstructive Pulmonary Disease Natasha Chowdhury.
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
Chronic Obstructive Pulmonary Disease and Asthma: All That Wheezes? Clifford Courville, MD Pulmonary, Allergy, and Critical Care.
COPD Management of Stable COPD Shyam Rao May 2014.
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
Diagnosing asthma History & Physical examination Measurements of lung function – Spirometry – Peak expiratory flow Measurements of airway hyperresponsiveness.
Do Now: review sheet questions 1-3 HW: Castle learning.
Surveillance for Asthma: Measuring a Moving Target David M. Mannino Air Pollution and Respiratory Health Branch Centers for Disease Control and Prevention.
 Smoking is the primary cause of avoidable death  Thousand of teens try cigarettes daily.  Smoking contributes to an astonishing number of diseases.
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
Case No. 12 SH, 25 years old with a history of asthma since childhood presented to the OPD clinic with complaints of worsening dyspnea and wheezing. He.
Lesson 4 Care and Problems of the Respiratory System Respiratory system problems can affect the functioning of other body systems. Imagine not being able.
By Dalia Munoz ASTHMA. is a serious and ongoing disease that affects the airways of both adults and children. Airways are the tubes that carry air in.
Asthma in Australia 2003 Figures from: Australian Centre for Asthma Monitoring 2003 Asthma in Australia 2003 AIHW Asthma Series 1. AIHW Cat. No. ACM 1.
Bronchitis Causes Bronchitis occurs most often during the cold and flu season, usually coupled with an upper respiratory infection. A number of bacteria.
WMMC Symposium. Centers For Disease Control What Is Chronic Obstructive Pulmonary Disease (COPD)?  COPD is the name for a group of diseases that restrict.
Global Health Assessment Strategies Ricardo Izurieta.
Manila, Philippines. BOLD Manila, Philippines  COPD a growing cause of morbidity & mortality worldwide  5 th leading cause of death (2001)  3rd in.
Assessing Risk (Future) Domain – Of adverse events in the future, especially of exacerbations and of progressive, irreversible loss of pulmonary function—is.
Renato B. Herradura, M.D. F.P.C.P. Antonio F.P.C.C.P. Pulmonary & Internal Medicine University of the East R Magsaysay Medical Center.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Chronic Obstructive Pulmonary Disease
Asthma A Presentation on Asthma Management and Prevention.
WP 4.1.Clinical Field Survey SINPHONIE Project kick-off meeting November, REC Conference Center, Szentendre Hungary Peter Rudnai National Institute.
Chronic Obstructive Pulmonary Disease Austin Paul K.
Integrated Management of Childhood Illnesses
GARD PROJECT IN CABO VERDE José Rosado Pinto GARD WHO Meeting Beijing March 2005 Serviço de Imunoalergologia, Hospital de Dona Estefânia Lisboa,
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Long-term Mortality Among Adults With Asthma A 25-Year Follow-up of 1,075 Outpatients With Asthma Zarqa Ali, MD; Christina Glattre Dirks, MD, PhD; and.
Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli1, Meredith C. McCormack, Eric Peng Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory.
Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Asthma 1 د. ميريانا البيضة. DIAGNOSIS 2 3 Definition of asthma.
Survey of Respiratory Diagnostic Laboratories to Inform the National COPD Strategy T McCarthy,* A McGowan, ¥ M O’Connor,* on behalf of the National COPD.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Materials and Methods Population Sampling. Nine hundred equestrian instructors were selected randomly from a database of approximately 2,500 certified.
Pneumonia Infection and inflammation of the lungs Alveoli fill with fluids and mucus resulting in coughing and difficulty breathing Treatment: medication.
Diagnosis of asthma in adolescents and adults D.Anan Esmail Seminar Training Primary Care Asthma+ COPD
COPD 2003.
External multicentric validation of a COPD detection questionnaire.
An effective COPD case finding strategy in Primary Care
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
Trends in Use of Pulmonary Rehabilitation Among Older Adults with Chronic Obstructive Pulmonary Disease Anita C. Mercado, Shawn P. Nishi, Wei Zhang, Yong-Fang.
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
Estimating need and coverage for chronic conditions through household surveys Ties Boerma, WHO, Geneva.
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
Greater Glasgow Outreach Spirometry Service: A model for closer collaboration between primary and secondary care and its impact on chronic lung disease.
Respiratory Disorders and Diseases
Prof Dr Guy JOOS Dept Respiratory Medicine Ghent University Hospital
Disorders of the Respiratory System
Asthma Allison Ormond, RN Pamlico County Primary School.
Asthma and COPD Hannah Bishop Advanced Nurse Practitioner
Presentation transcript:

Burden of major Respiratory Diseases WHO Survey Ryazan region of Russia,

RUSSIA

Ryazan region of Russia, health care system: 104 hospitals district hospitals – 32 rural hospitals – out-patient departments 792 “feldsher's” stations

Total area square kilometres. Density of population– 32 per square kilometre. Total population 1 mlln. 230 thousand people, live in Ryazan. 96% - Russians. Rural population – 31%. Shilovo district Population – Scopin district Population –

Protocol for assessment of prevalence of major respiratory diseases Prevalence survey of respiratory disease at the PHC level Prevalence survey of respiratory disease in a household manner Clinical survey and lung function test Pilot stage Number of patients October 2004March 2006

Pilot stage Obtaining the list of PHC Finalize the questionnaires and the GP’s, RT’s and LFT forms Training of the personnel Design, plan and execute pilot prevalence survey Determine whether the “cookbook” (protocol & manual of procedures) works Test communications

Prevalence survey of respiratory disease in a household manner Population: Individuals >= 5 years randomly selected Administered standardised questionnaire on symptoms, diseases, diagnoses, comorbidity, sociodemographics, risk factors

Clinical survey and lung function test PHS were randomized for the lung function test. All patients from the household stage were included.

Clinical survey and lung function test PHS were randomized for the lung function test. All patients from the household stage were included.

General characteristics of the study RegionStageStudy periodNumber of health facilities Number of patients Scopin districtPHC based Household based Clinical survey & lung function test Shilovo districtPHC based Household based Clinical survey & lung function test

Education level of respondents, %, by stages StageHigherSecond ary PrimaryNo edu- cation PHC based7,3859,2227,326,08 Household based 5,

Age distribution of risk factors, by stages (self-reported by patients) StageRisk factor5-14 years females/males years females/males >= 50 years females/males PHC based Worked for a year or more in any dusty job Ever smoked cigarettes Now smoke cigarettes Heat or cook using an open fire Household based Worked for a year or more in any dusty job Ever smoked cigarettes Now smoke cigarettes Heat or cook using an open fire

Age distribution of symptomatic respiratory patients, by stages (self-reported by patients) StageCough5-14 years females/males years females/males >= 50 years females/males PHC based usually have a cough 9,7612,6013,0026,7016,7143,97 usually cough as much as 4 to 6 times a day, 4 or more days out of the week 4,888,667,8317,7211,7832,17 Household based usually have a cough usually cough as much as 4 to 6 times a day, 4 or more days out of the week

Age distribution of symptomatic respiratory patients, by stages (self-reported by patients) StagePhlegm5-14 years females/males years females/males >= 50 years females/males PHC based usually bring up phlegm 8,136,307,1718,939,3833,24 usually bring up phlegm twice a day, 4 or more days out of the week 6,504,725,3314,567,6926,27 Household based usually bring up phlegm 0,440,212,299,065,3517,59 usually bring up phlegm twice a day,4 or more days out of theweek 0,220,211,004,974,2813,19

Age distribution of symptomatic respiratory patients, by stages (self-reported by patients) StageWheezing5-14 years females/males years females/males >= 50 years females/males PHC based ever had an attack of wheezing 13,8214,9615,1713,5916,5923,59 had 2 or more such episodes 9,7613,3912,0010,1914,0618,23 Househol d based ever had an attack of wheezing 2,643,133,582,937,179,18 had 2 or more such episodes 2,423,332,892,685,576,69

Age distribution of symptomatic respiratory patients, by stages (self-reported by patients) StageBreathless- ness 5-14 years females/males years females/males >= 50 years females/males PHC based MRC 16,500,7917,179,7152,0439,95 MRC 22,440,009,505,8343,5134,32 MRC 32,440,005,174,1331,1326,01 MRC 42,440,003,501,2119,7115,28 MRC 50,00 0,670,974,934,56 Household based MRC 10,220,008,162,4242,7226,39 MRC 20,220,215,471,4033,6220,27 MRC 30,000,422,890,3826,6616,06 MRC 40,000,211,290,5113,817,07 MRC 50,00 0,100,134,603,63

Prevalence of bronchial obstruction, % Stage5-14 years females/males years females/males >= 50 years females/males Household based clinical survey & lung function test FEV1/FVC <70 2,721,285, ,6523,72

Prevalence of smoking by Age & Sex, %

Bronchial obstruction degree Pack-years, mean Bronchial obstruction and smoking

Bronchial obstruction degree Part of patients with dyspnea Bronchial obstruction and dyspnea

Lung Disease and Respiratory Symptoms

Treatment Only 2 from 100 patients with respiratory symptoms and low pulmonary function regularly use inhalation of bronchodilators

Among the patients with bronchial asthma: –regularly use inhalation of glucocorticoids – less than 1% –regularly use inhalation of bronchodilators – 1,5% –regularly use theophylline – 15 % Treatment

“ Adequate education, should be available, in order to ensure correct diagnosis and treatment, in particular in primary care.”

Optimization of prophylactic programs for primary care settings to reduce risk factors Diagnostic algorithm for primary care settings based on the main symptoms and risk factors Using spirometry like routine method in primary care Optimization of rehabilitation program for primary care settings to reduce patients disability Educational program Key stones

Comparison of age distribution, in years, by stages between sexes StageMean age (+/- SD) in females Mean age (+/- SD) in males p PHC based49,5721,2942,4721,806,67535E-16 Household based41,0324,0434,8922,606,92384Е-17

Working population, %, by stages Stage5-14 years females/males years females/males >= 50 years females/males PHC based--72,0059,2216,7124,66 Household based--45,8745,1512,6317,97

Migrants, %, by stages Stage PHC based3.36 Household based3,21

Prevalence of respiratory diseases, by stages (self-reported by patients) StageDisease5-14 years females/males years females/males >= 50 years females/males PHC basedEmphysema0,00 0,501,462,768,58 Asthma4,076,303,834,134,334,29 Chronic bronchitis2,445,518,179,9515,1426,01 Tuberculosis0,00 0,171,940,362,95 Current pneumonia4,072,360,671,461,322,14 Allergic rhinitis5,691,573,503,882,401,07 Another respiratory disease* 45,5348,0327,6719,6614,7811,80 Household based Emphysema0,00 0,260,430,38 Asthma0,220,210,401,021,821,15 Chronic bronchitis0,221,464,785,9910,0616,06 Tuberculosis0,000,420,400,641,071,72 Current pneumonia0,00 0,400,640,321,15 Allergic rhinitis0,880,631,000,770,540,00 Another respiratory disease* 20,0422,5022,9920,4115,1013,19

Prevalence of respiratory diseases (reported by medics) StageDisease5-14 years15-49 years>= 50 years Household based clinical survey & lung function test Emphysema0,000,170,89 Asthma0,330,841,33 Chronic bronchitis 0,332,197,33 Tuberculosis0,000,340,22 Current pneumonia 2,002,024,00 Allergic rhinitis0,331,180,00

Main symptoms and medical diagnosis of chronic bronchitis Patients without established diagnosis Patients with established diagnosis Part of patients with symptoms CoughWheezing PhlegmDyspnea

Risk factors and chronic cough Patients without chronic cough Patients with chronic cough Part of patients with risk factors Work in any dusty job Heat or cook using an open fire Smoke

Risk factors and phlegm production Patients without phlegmPatients with phlegm Part of patients with risk factors Work in any dusty job Heat or cook using an open fire Smoke

Risk factors and wheezing Patients without wheezingPatients with wheezing Part of patients with risk factors Work in any dusty job Heat or cook using an open fire Smoke

Risk factors and dyspnea Patients without dyspneaPatients with dyspnea Part of patients with risk factors Work in any dusty job Heat or cook using an open fire Smoke

Risk factors and medical diagnosis of chronic bronchitis Patients without with established diagnosis Patients with with established diagnosis Part of patients with risk factors Work in any dusty job Heat or cook using an open fire Smoke

Bronchial obstruction degree Part of patients with risk factors Bronchial obstruction and risk factors

Bronchial obstruction degree Part of patients with established diagnosis Bronchial obstruction and medical diagnosis of chronic bronchitis

Bronchial obstruction degree Part of patients with chronic cough Bronchial obstruction and chronic cough

Bronchial obstruction degree Part of patients with phlegm production Bronchial obstruction and chronic phlegm productin

Bronchial obstruction degree Part of patients with wheezing Bronchial obstruction and weezing

Have ever taken drug for respiratory diseases StageDrug category5-14 years15-49 years>= 50 years Household based clinical survey & lung function test Antibiotics Inhalation bronchodilators Theophylline Mucolitics Inhalation glucocorticoids Oral steroids

Pilot stage Obtaining the list of PHC Finalize the questionnaires and the GP’s, RT’s and LFT forms Training of the personnel Design, plan and execute pilot prevalence survey Determine whether the “cookbook” (protocol & manual of procedures) works Test communications

Prevalence survey of respiratory disease in a household manner Population: Individuals >= 5 years randomly selected Administered standardised questionnaire on symptoms, diseases, diagnoses, comorbidity, sociodemographics, risk factors

Prevalence survey of respiratory disease at the PHC level Population: Individuals >= 5 years attending PHC Administered standardised questionnaire on symptoms, diseases, diagnoses, comorbidity, sociodemographics, risk factors